Word

V-PUPSIT

Status

Registered

Status Code

700

Status Date

Tuesday, April 23, 2024

Serial Number

79356168

Registration Number

7362174

Registration Date

Tuesday, April 23, 2024

Mark Type

4

Filing Date

Wednesday, June 15, 2022

Published for Opposition

Tuesday, February 6, 2024

Trademark Owner History

Vetter Pharma-Fertigung GmbH & Co. KG - Original Registrant

Classifications

39 Bottling services, namely, aseptic, sterile bottling of substances

5 Aseptically manufactured pharmaceutical preparations and drugs for the prevention of infections, cancer, depression, heart diseases, vascular diseases, and intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; pharmaceutical preparations to be taken orally and sterile, aseptic solutions and injection solutions for the prevention of infections, cancer, depression, heart diseases, vascular diseases, and intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; eye drops, contact lens solutions; swabs for medical purposes; medical plasters; materials for medical dressings, namely, compresses, sterile pads, gauze, plastic films, gels, foams, hydrocolloids, alginates, pastes, granules and beads

42 Scientific research and development in the field of aseptic and sterile bottling services of substances and syringes for injections and instruments, injectors and associated packaging; engineering services, namely, chemical, physical and process engineering laboratory testing; testing of pharmaceuticals, namely, conducting of microbiological tests and procedures for others

Trademark Events

Mar 29, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Dec 1, 2022

Sn Assigned For Sect 66a Appl From Ib

Dec 2, 2022

New Application Office Supplied Data Entered

Dec 6, 2022

Application Filing Receipt Mailed

Mar 28, 2023

Assigned To Examiner

Mar 28, 2023

Non-Final Action Written

May 17, 2023

Refusal Processed By Mpu

May 17, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Jun 12, 2023

Refusal Processed By Ib

Nov 14, 2023

Teas Response To Office Action Received

Nov 14, 2023

Correspondence Received In Law Office

Nov 15, 2023

Teas/Email Correspondence Entered

Nov 20, 2023

Assigned To Examiner

Jan 17, 2024

Notification Of Possible Opposition Sent To Ib

Jan 17, 2024

Notification Of Notice Of Publication E-Mailed

Jan 17, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Feb 6, 2024

Notification Processed By Ib

Jan 4, 2024

Approved For Pub - Principal Register

Feb 6, 2024

Published For Opposition

Feb 6, 2024

Official Gazette Publication Confirmation E-Mailed

Apr 23, 2024

Registered-Principal Register

Apr 23, 2024

Notice Of Registration Confirmation Emailed

Jul 24, 2024

Final Disposition Notice Created, To Be Sent To Ib